Vertex, CRISPR score landmark FDA approval for sickle cell disease gene therapy Casgevy
Fierce Pharma
DECEMBER 8, 2023
Vertex Pharmaceuticals and CRISPR Therapeutics have won an historic FDA approval for their sickle cell disease gene therapy Casgevy. Groundbreaking? Game-changing? Transformational?
Let's personalize your content